Excellent outcome of acute lymphoblastic leukaemia with TCF3-PBX1 rearrangement in Hong Kong.
Anna LinFrankie W T ChengAlan K S ChiangChung-Wing LukRever C H LiAlvin S C LingDaniel K L CheukKai-On ChangDennis Tak-Loi KuVincent LeeShau-Yin HaChi-Kong LiPublished in: Pediatric blood & cancer (2018)
This population-based study over the past 20 years demonstrated that patients with TCF3-PBX1 rearrangement had favourable EFS compared with other intermediate risk patients treated with a similar chemotherapy backbone.